文献速递神经头颈PETMR

68Ga-DOTATATE PET在神经鞘瘤中的表现:支持无创诊断的独特摄取模式

68GA DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-07-01

回顾性分析16例影像学诊断为神经鞘瘤的患者,所有病灶在68Ga-DOTATATE PET上均表现为极低摄取,平均病灶最大SUV为1.6±0.7,平均SUVRSSS为1.5±0.7,远低于脑膜瘤诊断的既定阈值,提示该检查可能有助于无创鉴别神经鞘瘤与表达SSTR2的肿瘤。

要点

  • 神经鞘瘤在68Ga-DOTATATE PET上呈极低摄取,平均最大SUV 1.6±0.7。
  • 平均SUVRSSS为1.5±0.7,远低于脑膜瘤诊断的既定阈值。
  • 68Ga-DOTATATE PET可能有助于鉴别神经鞘瘤与SSTR2表达肿瘤。

核心结论

  • 神经鞘瘤在68Ga-DOTATATE PET上表现为极低摄取,与脑膜瘤等表达SSTR2的肿瘤形成对比,可能有助于在MRI特征重叠的诊断困难病例中无创鉴别神经鞘瘤与表达SSTR2的肿瘤。

研究设计与样本

  • 回顾性研究,纳入16例影像学诊断为神经鞘瘤的患者,均接受68Ga-DOTATATE PET/MRI或PET/CT检查,测量病灶最大SUV、上矢状窦SUV及SUVRSSS。

关键影像表现/征象

  • 所有神经鞘瘤病灶均表现为极低的68Ga-DOTATATE摄取。
  • 平均病灶最大SUV为1.6±0.7。
  • 平均SUVRSSS为1.5±0.7。

诊断标准与关键数值

  • 神经鞘瘤的平均最大SUV为1.6±0.7,平均SUVRSSS为1.5±0.7,均远低于脑膜瘤诊断的既定阈值。

临床应用与阅片要点

  • 在MRI特征重叠、难以鉴别神经鞘瘤与脑膜瘤等SSTR2表达肿瘤的病例中,68Ga-DOTATATE PET可能有助于无创鉴别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Schwannomas are a key diagnostic consideration in patients with enhancing extra-axial intracranial, skull base, and neck masses. While contrast-enhanced MRI is the diagnostic mainstay, its specificity can be limited, especially in small or atypical lesions. [68GA]DOTATATE PET/MRI and PET/CT, which target somatostatin receptor subtype 2 (SSTR2), represent an established tool in evaluating SSTR2-positive tumors, most notably meningiomas and paragangliomas, entities that can mimic schwannomas on conventional MRI. However, data on SSTR2 expression in schwannomas remain limited. We aimed to characterize [68GA]DOTATATE PET imaging features in patients with imaging-defined schwannomas.

MATERIALS AND METHODS: We retrospectively identified patients who underwent [68GA]DOTATATE PET/MRI or PET/CT for evaluation of known or suspected SSTR2-positive tumors and had MRI features diagnostic of schwannoma. PET/CT or PET/MRI was performed as part of clinical evaluation according to previously published institutional protocols. Lesion maximum standardized uptake values (SUV), superior sagittal sinus (SSS) SUV (blood pool reference), and SUV ratios relative to the SSS (SUVRSSS) were measured.

RESULTS: Sixteen patients met the inclusion criteria (mean age 62.1 ± 13.4 years; 43.8% women). The cohort included 6 patients with isolated schwannomas and 10 with concurrent meningiomas. None had prior radiotherapy. All lesions demonstrated minimal [68GA]DOTATATE avidity; the mean maximum lesion SUV was 1.6 ± 0.7, and the mean SUVRSSS was 1.5 ± 0.7, values well below established thresholds for meningioma diagnosis.

CONCLUSIONS: Schwannomas exhibit minimal [68GA]DOTATATE avidity, in contrast to SSTR2-expressing tumors such as meningiomas. [68GA]DOTATATE PET may therefore aid in noninvasively differentiating schwannomas from SSTR2-expressing tumors with overlapping MRI features in diagnostically challenging cases.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Luck S, Sathi N, Shaqra H, et al. 68GA DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis. AJNR Am J Neuroradiol. 2026. PMID: 41617401. doi:10.3174/ajnr.A9183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。